Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 9, 2018
Genocea Announces Upcoming Presentations at SITC 2018
CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc.(GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced the titles and times of ...
October 9, 2018
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
VANCOUVER, Oct. 9, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NVCN) (NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve ...
October 4, 2018
Spring Bank Announces Inarigivir Data Presentations at AASLD Conference
HOPKINTON, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
October 4, 2018
Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop Next-Generation Allogeneic CAR-T Therapies
MONT-SAINT-GUIBERT, Belgium, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
October 4, 2018
Celyad to Present CYAD-01 Solid Tumor Clinical Updates and Pre-Clinical Pipeline Data at the 2018 SITC Annual Meeting
MONT-SAINT-GUIBERT, Belgium, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
October 4, 2018
Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome
Copenhagen, October 4 2018 - Zealand Pharma A/S ("Zealand") (ZEAL), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today ...
October 4, 2018
Sierra Oncology to Host KOL Call with Dr. Srdan Verstovsek Presenting "Unmet Medical Needs in Myelofibrosis"
VANCOUVER, Oct. 4, 2018 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of ...
October 4, 2018
Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator
DURHAM, NC / ACCESSWIRE / October 4, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system ...
October 4, 2018
Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen
PASADENA, Calif.--(BUSINESS WIRE)-- - Upon closing, Arrowhead to receive $250 million, consisting of $175 million upfront payment from Janssen and $75 million equity investment from ...
October 4, 2018
Noxopharm Releases Report on Key Progress of Subsidiary Nyrada
SYDNEY, Australia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Noxopharm (ASX:NOX) today releases a Report sent to the Convertible Note holders who in February 2018 provided ...
October 4, 2018
MannKind Presents Positive Afrezza® STAT Study Clinical Data at 54th Annual Meeting of the European Association for the Study of Diabetes
WESTLAKE VILLAGE, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), a company focused on the development and commercialization of inhaled therapeutic products for ...
October 3, 2018
BioLineRx Increases Stake in BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications
TEL AVIV, Israel, Oct. 3, 2018 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it ...
October 3, 2018
BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS
NEW YORK and PETACH TIKVAH, Israel, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of innovative adult stem cell ...
October 3, 2018
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company ...
October 3, 2018
CytoSorbents to Present at the Cantor Fitzgerald Global Healthcare Conference
MONMOUTH JUNCTION, N.J., Oct. 3, 2018 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in ...
October 3, 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer™
VANCOUVER, Oct. 3, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
October 3, 2018
Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
NASHUA, N.H. and SIOUX FALLS, S.D., Oct. 03, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy ...
October 3, 2018
Altimmune Closes on $16.9 Million in Funding
GAITHERSBURG, Md., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced it closed the previously announced underwritten public offering ...
October 3, 2018
Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterial agents to address ...
October 3, 2018
MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes
WESTLAKE VILLAGE, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), announced that it presented new scientific data in an oral and poster presentation ...
Page 46 of 150